CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

CorMedix (Nasdaq: CRMD) will report first quarter 2026 financial results for the period ended March 31, 2026, before the market opens on Thursday, May 14, 2026.

Rhea-AI Summary

CorMedix (Nasdaq: CRMD) will report first quarter 2026 financial results for the period ended March 31, 2026, before the market opens on Thursday, May 14, 2026. The company will host a corporate update conference call at 8:30am Eastern Time with domestic and international dial-in numbers and a webcast.

Argus May 5 session

-2.15% close to close Open Argus

Details

News Market Reaction – CRMD

In the May 5 session, CRMD declined 2.15%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules CRMD’s Q1 2026 results for May 14, 2026 with a corporate update call at ...

Analysis

This announcement schedules CRMD’s Q1 2026 results for May 14, 2026 with a corporate update call at 8:30am ET. It follows a period of strong reported 2025 performance, including net income of $163.0M and pro forma revenue of $401.3M. As investors look ahead, key items to watch will be updated revenue and EBITDA trends, progress on DefenCath and REZZAYO, and any revisions to the company’s previously disclosed guidance.

Key Figures

Earnings release date: May 14, 2026 Conference call time: 8:30am ET Q4 2025 net revenue: $128.6M +5 more

Earnings release date

May 14, 2026

Q1 2026 financial results before market open

Conference call time

8:30am ET

Q1 2026 corporate update call

Q4 2025 net revenue

$128.6M

Fourth quarter 2025 results

Pro forma 2025 revenue

$401.3M

Full-year 2025, assuming full-year Melinta

2025 net income

$163.0M

Full-year 2025, turning prior-year loss to profit

2026 revenue guidance

$300–$320M

Company outlook from March 6, 2026 8-K

2027 DefenCath sales guidance

$100–$140M

Full-year 2027 DefenCath estimate from 8-K

Resale shelf shares

6,323,833 shares

S-3ASR registered for selling securityholders

Previous Earnings date Reports

1 past event · Latest: Mar 02

Same Type 1 event

1. Mar 02

   Earnings date notice

   24h Move

   +1.1%

   Scheduled Q4 and full-year 2025 earnings release with 8:30am ET call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the first quarter ended March 31, 2026, before the market opens on Thursday, May 14, 2026, and will host a corporate update conference call at 8:30am Eastern Time.

Thursday, May 14th @ 8:30am ET
Domestic:	1-844-676-2922
International:	1-412-634-6840
Webcast:	Webcast Link

About CorMedix
CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit: www.cormedix.com.

Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will CorMedix (CRMD) report Q1 2026 results and hold the corporate update call?

CorMedix will report Q1 2026 results before market open on May 14, 2026 and hold a corporate update call at 8:30am ET. According to CorMedix, the call follows the release and includes dial-in and webcast access for investors.

How can investors join the CorMedix (CRMD) May 14, 2026 conference call?

Investors can join by phone or webcast for the May 14, 2026 call at 8:30am ET. According to CorMedix, domestic dial-in is 1-844-676-2922, international dial-in is 1-412-634-6840, and a webcast link is provided.

What time should shareholders tune in for CorMedix (CRMD) corporate update on May 14, 2026?

Shareholders should tune in at 8:30am Eastern Time on May 14, 2026 for the corporate update call. According to CorMedix, the company will release Q1 2026 results before market open and then host the call at that scheduled time.

Will CorMedix (CRMD) release Q1 2026 financials before or after market open on May 14, 2026?

CorMedix will release Q1 2026 financial results before the market opens on May 14, 2026. According to CorMedix, the results will be followed by a corporate update conference call at 8:30am Eastern Time with webcast access.

Where can I find the CorMedix (CRMD) webcast for the May 14, 2026 update?

A webcast will be available for the May 14, 2026 corporate update at 8:30am ET. According to CorMedix, investors can access the live webcast via the provided webcast link accompanying the company announcement and dial-in details.